Anglo-French Drugs & Industries reports standalone net loss of Rs 3.35 crore in the December 2023 quarter
Written by: Planify
Published: 15 February 2024
Updated: 20 February 2024
1 min read
Net Loss of Anglo-French Drugs & Industries reported to Rs 3.35 crore in the quarter ended December 2023 as against net loss of Rs 7.06 crore during the previous quarter ended December 2022. Sales rose 36.78% to Rs 25.66 crore in the quarter ended December 2023 as against Rs 18.76 crore during the previous quarter ended December 2022.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
